Patient Guide: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 31 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04431726
Status: ACTIVE_NOT_RECRUITING
Condition: Hemophilia A
Phase: PHASE3

Where You Can Participate

This study is available at 31 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Los Angeles, California
  • • Aurora, Colorado
  • • And 28 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors - Join Clinical Trial NCTNCT04431726

How to Join This Clinical Trial - NCTNCT04431726

Learn how to participate in this PHASE3 trial studying an investigational therapy for Hemophilia A. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hemophilia A. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hemophilia A
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04431726 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 31 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85016 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90027 - United States

Status: Contact for availability

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: Contact for availability

Clinical Research Site

New Orleans, Louisiana 70112 - United States

Status: Contact for availability

Clinical Research Site

Ann Arbor, Michigan 48109-0934 - United States

Status: Contact for availability

Clinical Research Site

Seattle, Washington 98105 - United States

Status: Contact for availability

Clinical Research Site

Westmead, New South Wales 2145 - Australia

Status: Contact for availability

Clinical Research Site

Parkville, Victoria 3052 - Australia

Status: Contact for availability

Clinical Research Site

Nedlands, Western Australia 6009 - Australia

Status: Contact for availability

Clinical Research Site

Wien, 1090 - Austria

Status: Contact for availability

And 21 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Hemophilia A:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships